FALCO, Angela
 Distribuzione geografica
Continente #
NA - Nord America 2.150
EU - Europa 1.535
AS - Asia 1.497
SA - Sud America 233
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 5.488
Nazione #
US - Stati Uniti d'America 2.102
SG - Singapore 553
CN - Cina 537
IT - Italia 429
IE - Irlanda 260
SE - Svezia 245
BR - Brasile 182
DE - Germania 150
FI - Finlandia 148
HK - Hong Kong 130
VN - Vietnam 97
TR - Turchia 54
FR - Francia 50
NL - Olanda 48
ZA - Sudafrica 48
GB - Regno Unito 47
CA - Canada 34
IN - India 28
BD - Bangladesh 25
BE - Belgio 24
AT - Austria 23
RU - Federazione Russa 21
CZ - Repubblica Ceca 20
AR - Argentina 19
PL - Polonia 17
LT - Lituania 12
IQ - Iraq 11
JP - Giappone 11
MX - Messico 10
UA - Ucraina 10
ES - Italia 9
ID - Indonesia 9
EC - Ecuador 8
MA - Marocco 8
UZ - Uzbekistan 8
CI - Costa d'Avorio 7
PK - Pakistan 7
RO - Romania 6
CO - Colombia 5
JO - Giordania 5
KR - Corea 5
UY - Uruguay 5
VE - Venezuela 5
CH - Svizzera 4
PY - Paraguay 4
AU - Australia 3
BY - Bielorussia 3
EU - Europa 3
AZ - Azerbaigian 2
CL - Cile 2
EG - Egitto 2
GR - Grecia 2
IR - Iran 2
NI - Nicaragua 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BT - Bhutan 1
DZ - Algeria 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MT - Malta 1
NP - Nepal 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TW - Taiwan 1
Totale 5.488
Città #
Chandler 308
Singapore 294
Ashburn 291
Dublin 260
Dallas 223
Parma 168
Hong Kong 126
Santa Clara 122
Beijing 106
Ann Arbor 96
Boardman 93
Shanghai 72
New York 69
Dearborn 67
Munich 65
Nanjing 60
Padova 57
Izmir 46
Johannesburg 46
Los Angeles 43
Helsinki 39
Princeton 38
Ho Chi Minh City 35
Bremen 33
Wilmington 29
Nanchang 23
Brussels 22
Buffalo 21
São Paulo 20
Vienna 20
Columbus 17
Hanoi 17
Hebei 17
Jinan 15
Moscow 15
Turku 15
Dong Ket 14
San Mateo 14
Warsaw 14
Frankfurt am Main 13
Milan 13
Seattle 13
Shenyang 13
Brooklyn 12
London 12
Norwalk 12
Pune 12
Bologna 11
Guangzhou 11
Hefei 11
Woodbridge 11
Denver 10
Kunming 10
Stockholm 10
The Dalles 10
Toronto 10
Atlanta 9
Brno 9
Council Bluffs 9
Rio Saliceto 9
Zhengzhou 9
Carpi 8
Changsha 8
Nuremberg 8
Tianjin 8
Tokyo 8
Abidjan 7
Des Moines 7
Fremont 7
Haiphong 7
Jacksonville 7
Jakarta 7
Jiaxing 7
Marseille 7
Montreal 7
Rio de Janeiro 7
Chennai 6
Houston 6
Olomouc 6
Redwood City 6
Amman 5
Amsterdam 5
Baghdad 5
Chicago 5
Fuzhou 5
Hangzhou 5
Phoenix 5
Poplar 5
Redondo Beach 5
Reggio Emilia 5
San Jose 5
Sector 6 5
Seoul 5
Tashkent 5
Brasília 4
Contagem 4
Edinburgh 4
Genova 4
Hải Dương 4
Mexico City 4
Totale 3.497
Nome #
Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol 239
Subchronic exposure to titanium dioxide nanoparticles modifies cardiac structure and performance in spontaneously hypertensive rats 200
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors 183
A Hybrid In Silico/In Vitro Target Fishing Study to Mine Novel Targets of Urolithin A and B: A Step Towards a Better Comprehension of their Estrogenicity 174
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 172
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 168
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. 164
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. 163
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 157
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation 156
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method 155
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 153
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 151
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 147
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 146
Trimethylamine-N-Oxide (TMAO)-Induced Impairment of Cardiomyocyte Function and the Protective Role of Urolithin B-Glucuronide 145
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 138
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 138
Assessment of Cardiac Patches Suitability for Tissue Engineering 137
Isolation and characterization of human lung lymphatic endothelial cells 135
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 132
Dissecting the cellular mechanisms of cardiotoxicity by anthracycline and tyrosine kinase inhibitors 131
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 131
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 129
Bioactive Electrospun Fibers of Poly(glycerol sebacate) and Poly(ε-caprolactone) for Cardiac Patch Application 127
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 125
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 118
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 116
GCN5 contributes to intracellular lipid accumulation in human primary cardiac stromal cells from patients affected by Arrhythmogenic cardiomyopathy 113
Differential Pattern of Myocardial Remodelling in Genetically Determined and Load- Dependent Hypertrophy in Humans 110
Development of biomimetic alginate/gelatin/elastin sponges with recognition properties toward bioactive peptides for cardiac tissue engineering 107
IMPACT OF THE TISSUE DISTRIBUTION OF SUBPOPULATIONS OF TILS AND PD-L1 EXPRESSION ON THE CLINICAL OUTCOME OF NSCLC 105
LUNG MESENCHYMAL STEM CELLS FUNCTION AS THE INDUCTIVE MICROENVIRONMENT FOR HUMAN LUNG CANCER PROPAGATING CELLS 97
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 97
IGF-1 loaded injectable microspheres for potential repair of the infarcted myocardium 96
Correction: A versatile bioreactor for dynamic suspension cell culture. Application to the culture of cancer cell spheroids 90
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 89
Influence of injectable microparticle size on cardiac progenitor cell response 86
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells 85
Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC 82
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC 76
Reinforced alginate/gelatin sponges functionalized by avidin/biotin-binding strategy: a novel cardiac patch 75
In vitro suspension bioreactor-based platform for culturing tumor cell clusters 72
Totale 5.610
Categoria #
all - tutte 19.724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.724


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021144 0 0 0 0 0 24 10 23 35 9 19 24
2021/2022174 10 9 8 12 4 3 24 13 4 12 5 70
2022/20231.111 98 132 68 93 120 116 21 76 313 7 57 10
2023/2024453 18 36 8 17 48 100 36 21 14 38 58 59
2024/20251.139 25 50 82 91 131 94 72 62 126 97 114 195
2025/20261.533 264 253 335 253 352 76 0 0 0 0 0 0
Totale 5.610